Keyword Search Year None20232022202120202019201820172016 Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008 May 25, 2023 Relay Therapeutics to Participate in Two Upcoming Investor Conferences May 24, 2023 Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights May 4, 2023 Relay Therapeutics to Announce First Quarter 2023 Financial Results and Corporate Highlights April 27, 2023 Relay Therapeutics to Participate in Two Upcoming Investor Conferences April 19, 2023 Relay Therapeutics Announces Initial Clinical Data Demonstrating that RLY-2608 Selectively Targets Multiple PI3Kα Mutations April 18, 2023 Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR March 6, 2023 Relay Therapeutics to Participate in Two Upcoming Investor Conferences March 1, 2023 Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights February 23, 2023 Relay Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights February 16, 2023 Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day February 2, 2023 Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference January 3, 2023
Relay Therapeutics to Announce First Quarter 2023 Financial Results and Corporate Highlights April 27, 2023
Relay Therapeutics Announces Initial Clinical Data Demonstrating that RLY-2608 Selectively Targets Multiple PI3Kα Mutations April 18, 2023
Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights February 23, 2023
Relay Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights February 16, 2023